Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/32390| Title: | Living evidence synthesis 25.1: Effectiveness of trivalent and quadrivalent influenza vaccines in preventing infection, hospitalization, and severe outcomes in the 2023–2024 season onwards |
| Authors: | Wu, N Bain, T Bhuiya, AR Phelps, A Dass, R Sivanesanathan, T Wilson, MG |
| Keywords: | trivalent;quadrivalent;influenza;vaccines;infection;hospitalization |
| Publication Date: | Nov-2024 |
| Citation: | Wu N, Bain T, Bhuiya A, Phelps A, Dass R, Sivanesanathan T, Wilson MG. Living evidence synthesis 25.1. Effectiveness of trivalent and quadrivalent influenza vaccines in preventing infection, hospitalization, and severe outcomes in the 2023–2024 season onwards. Hamilton: McMaster Health Forum, 7 November 2024. |
| Series/Report no.: | LES 25.1; |
| Abstract: | An in-depth synthesis of what is known, based on the best available research evidence from around the world (i.e., evidence syntheses) and local research evidence (i.e., single studies), about the effectiveness of trivalent and quadrivalent influenza vaccines in preventing infection, hospitalization, and severe outcomes in the 2023–2024 season onwards. |
| URI: | http://hdl.handle.net/11375/32390 |
| Appears in Collections: | Living evidence synthesis |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Living Evidence Synthesis 25.1 - Effectiveness of trivalent and quadrivalent influenza vaccines in preventing infection, hospitalization, and severe outcomes in the 2023-2024 season onwards.pdf | 397.21 kB | Adobe PDF | View/Open | |
| Living Evidence Synthesis 25.1 - Appendices.pdf | 510.52 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License
